Y.B Urban Renewal - Residential Development LTD Logo

Y.B Urban Renewal - Residential Development LTD

A company focused on urban renewal projects and residential development initiatives.

CSURE-M | TA

Overview

Corporate Details

ISIN(s):
IL0001110134
LEI:
Country:
Israel
Address:
2 Hahadarim Street, 7712102 Ashdod

Description

Y.B Urban Renewal - Residential Development LTD is a company focused on urban renewal projects. Formerly known as Cannassure Therapeutics Ltd, the company has transitioned from the medical cannabis sector. Its current mission is to facilitate the economic, cultural, and environmental renewal of inner-city areas through residential development initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 19:43
Trading in the company's shares (ISIN IL0001110134) will be renewed on Monday, …
Hebrew (modern) 113.5 KB
2025-05-05 15:53
The securities not included in the Illiquid list as of May 4th 2025 due to mar…
Hebrew (modern) 217.1 KB
2025-05-05 11:32
Suspension of trading due to failure in publication of financial reports s for …
Hebrew (modern) 79.7 KB
2025-04-28 18:40
Securities that have joined the program and the Market Makers that will operate…
Hebrew (modern) 366.8 KB
2025-04-20 18:21
Failure in publishing financial reports-Notification
Hebrew (modern) 128.0 KB
2025-03-06 18:39
Illiquid Candidates securities list as of May 4th 2025
Hebrew (modern) 245.6 KB
2024-07-28 18:05
The company's securities will be transferred from the maintenance list to the m…
Hebrew (modern) 106.5 KB
2024-07-11 17:14
Changes in the company's share symbol correction: YBRD-M
Hebrew (modern) 104.0 KB
2024-07-09 17:01
Changes in the company's name and security, effective as of July 11, 2024
Hebrew (modern) 105.9 KB
2024-06-25 19:48
Changes in Sector Classification of Listed Companies as of Sunday, June 30, 2024
Hebrew (modern) 135.9 KB
2024-03-21 18:45
Will trade on Monday March 25 2024, with unlimited price fluctuation at the ope…
Hebrew (modern) 137.2 KB
2023-07-13 20:43
Transfer to the Maintenance List on July 17, 2023
Hebrew (modern) 149.7 KB
2023-07-03 19:48
Companies that do not comply with the Maintenance Rules and are candidates to b…
Hebrew (modern) 116.3 KB
2023-01-15 17:37
Non-Compliance with the Maintenance Rules Based on Data as of December 31, 2022…
Hebrew (modern) 132.9 KB
2021-01-07 15:45
On Sunday, 10 January 2021, trading will commence in the following Security: CA…
Hebrew (modern) 186.1 KB

Automate Your Workflow. Get a real-time feed of all Y.B Urban Renewal - Residential Development LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Y.B Urban Renewal - Residential Development LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Y.B Urban Renewal - Residential Development LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.